The push to reduce carbon emissions across some of the most energy-intensive industries has created new complexities for many companies.
The push to reduce carbon emissions across some of the most energy-intensive industries has created new complexities for many companies. For the pharmaceutical industry, working toward net zero can be particularly complicated, as it means targeting improvements within a manufacturing paradigm that is largely outsourced to contract development and manufacturing organizations (CDMOs).
Fill out the form to download the white paper >>>>>